203 related articles for article (PubMed ID: 32053263)
1. Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.
Eriksson J; Le Joncour V; Jahkola T; Juteau S; Laakkonen P; Saksela O; Hölttä E
Mol Oncol; 2020 Apr; 14(4):742-762. PubMed ID: 32053263
[TBL] [Abstract][Full Text] [Related]
2. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of P4HA1 inhibits neovascularization via targeting glioma stem cell-endothelial cell transdifferentiation and disrupting vascular basement membrane.
Zhou Y; Jin G; Mi R; Zhang J; Zhang J; Xu H; Cheng S; Zhang Y; Song W; Liu F
Oncotarget; 2017 May; 8(22):35877-35889. PubMed ID: 28415787
[TBL] [Abstract][Full Text] [Related]
4. Collagen Prolyl Hydroxylases Are Bifunctional Growth Regulators in Melanoma.
Atkinson A; Renziehausen A; Wang H; Lo Nigro C; Lattanzio L; Merlano M; Rao B; Weir L; Evans A; Matin R; Harwood C; Szlosarek P; Pickering JG; Fleming C; Sim VR; Li S; Vasta JT; Raines RT; Boniol M; Thompson A; Proby C; Crook T; Syed N
J Invest Dermatol; 2019 May; 139(5):1118-1126. PubMed ID: 30452903
[TBL] [Abstract][Full Text] [Related]
5. MiR-122 inhibits epithelial mesenchymal transition by regulating P4HA1 in ovarian cancer cells.
Duan Y; Dong Y; Dang R; Hu Z; Yang Y; Hu Y; Cheng J
Cell Biol Int; 2018 Nov; 42(11):1564-1574. PubMed ID: 30136751
[TBL] [Abstract][Full Text] [Related]
6. Identification of P4HA1 as a prognostic biomarker for high-grade gliomas.
Hu WM; Zhang J; Sun SX; Xi SY; Chen ZJ; Jiang XB; Lin FH; Chen ZH; Chen YS; Wang J; Yang QY; Guo CC; Mou YG; Chen ZP; Zeng J; Sai K
Pathol Res Pract; 2017 Nov; 213(11):1365-1369. PubMed ID: 28964577
[TBL] [Abstract][Full Text] [Related]
7. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
[TBL] [Abstract][Full Text] [Related]
8. High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent-free survival in head and neck squamous cell carcinoma.
Li Q; Shen Z; Wu Z; Shen Y; Deng H; Zhou C; Liu H
J Clin Lab Anal; 2020 Mar; 34(3):e23107. PubMed ID: 31782831
[TBL] [Abstract][Full Text] [Related]
9. Systematic Analysis of the Expression and Prognostic Significance of P4HA1 in Pancreatic Cancer and Construction of a lncRNA-miRNA-P4HA1 Regulatory Axis.
Hu Z; Song F; Hu Y; Liao T
Biomed Res Int; 2020; 2020():8877334. PubMed ID: 33415167
[TBL] [Abstract][Full Text] [Related]
10. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition.
Xiong G; Deng L; Zhu J; Rychahou PG; Xu R
BMC Cancer; 2014 Jan; 14():1. PubMed ID: 24383403
[TBL] [Abstract][Full Text] [Related]
11. The miR-124-prolyl hydroxylase P4HA1-MMP1 axis plays a critical role in prostate cancer progression.
Chakravarthi BV; Pathi SS; Goswami MT; Cieślik M; Zheng H; Nallasivam S; Arekapudi SR; Jing X; Siddiqui J; Athanikar J; Carskadon SL; Lonigro RJ; Kunju LP; Chinnaiyan AM; Palanisamy N; Varambally S
Oncotarget; 2014 Aug; 5(16):6654-69. PubMed ID: 25115393
[TBL] [Abstract][Full Text] [Related]
12. P4HA1 expression and function in esophageal squamous cell carcinoma.
Gou W; Song B; Yang Y
Medicine (Baltimore); 2023 Dec; 102(51):e36800. PubMed ID: 38134053
[TBL] [Abstract][Full Text] [Related]
13. Identification of Potential Diagnostic and Prognostic Values of
Li M; Wu F; Zheng Q; Wu Y; Wu Y
DNA Cell Biol; 2020 May; 39(5):909-917. PubMed ID: 32150689
[TBL] [Abstract][Full Text] [Related]
14.
Sato K; Sano D; Takahashi H; Kuwahara T; Aizawa Y; Aoyama J; Nojima Y; Hatano T; Arai Y; Nishimura G; Hatakeyama H; Oridate N
Anticancer Res; 2023 Jun; 43(6):2571-2582. PubMed ID: 37247900
[TBL] [Abstract][Full Text] [Related]
15. Targeting HIF-activated collagen prolyl 4-hydroxylase expression disrupts collagen deposition and blocks primary and metastatic uveal melanoma growth.
Kaluz S; Zhang Q; Kuranaga Y; Yang H; Osuka S; Bhattacharya D; Devi NS; Mun J; Wang W; Zhang R; Goodman MM; Grossniklaus HE; Van Meir EG
Oncogene; 2021 Aug; 40(33):5182-5191. PubMed ID: 34218269
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-inducible factor 1 (HIF-1) promotes extracellular matrix remodeling under hypoxic conditions by inducing P4HA1, P4HA2, and PLOD2 expression in fibroblasts.
Gilkes DM; Bajpai S; Chaturvedi P; Wirtz D; Semenza GL
J Biol Chem; 2013 Apr; 288(15):10819-29. PubMed ID: 23423382
[TBL] [Abstract][Full Text] [Related]
17. Multilevel chitosan-gelatin particles loaded with P4HA1 siRNA suppress glioma development.
Zhou Y; Tian J; Zhu Y; Zhang Y; Zhao X
Drug Deliv Transl Res; 2024 Mar; 14(3):665-677. PubMed ID: 37667088
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-induced P4HA1 overexpression promotes post-ischemic angiogenesis by enhancing endothelial glycolysis through downregulating FBP1.
Xu Y; Xia D; Huang K; Liang M
J Transl Med; 2024 Jan; 22(1):74. PubMed ID: 38238754
[TBL] [Abstract][Full Text] [Related]
19. P4HA1 activates HMGCS1 to promote nasopharyngeal carcinoma ferroptosis resistance and progression.
Zhou R; Qiu L; Zhou L; Geng R; Yang S; Wu J
Cell Signal; 2023 May; 105():110609. PubMed ID: 36702290
[TBL] [Abstract][Full Text] [Related]
20. P4HA1, transcriptionally activated by STAT1, promotes esophageal cancer progression.
Gou W; Yang Y; Shan Q; Xia S; Ma Y
Pathol Int; 2023 Apr; 73(4):147-158. PubMed ID: 36734588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
